Skip to content

Observational study for lymphoproliferative disorders in patients with rheumatoid arthritis

Observational study for lymphoproliferative disorders in patients with rheumatoid arthritis - Observational study for lymphoproliferative disorders in patients with rheumatoid arthritis (RA-LPD study)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000022942
Enrollment
57500
Registered
2016-07-01
Start date
2016-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

None listed

Sponsors

Japan College of Rheumatology
Lead Sponsor
Osaka University Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. From 2011.4.1 to 2011.7.31, Japanese rheumatoid arthritis (RA) patients who were 20 years old or older, and visited at least once the RA educational institutions that were authorized by Japan College of Rheumatology, and agreed to participate in this study 2. RA patients who were fulfilled the 1987 American College of Rheumatology classification criteria for RA or American College of Rheumatology/European League Against Rheumatism classification criteria for RA

Exclusion criteria

Exclusion criteria: 1. Patients who were definitely diagnosed with lymphoma based on pathological data before the start of observation 2. Patients or their deputies who did not agree to participate in this study 3. Patients who were deemed to be unqualified due to medical or social reasons by attending physicians

Design outcomes

Primary

MeasureTime frame
Incidence rate of lymphoproliferative disorders over three years in patients with rheumatoid arthritis

Secondary

MeasureTime frame
Prognosis of the registered patients with rheumatoid arthritis over three years, and clinical characteristics and treatments for LPD

Countries

Japan

Contacts

Public ContactRyoko Sakai

Tokyo Women's Medical University Institute of Rheumatology Department of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases

sakai.ryoko@twmu.ac.jp03-5269-1725

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026